[go: up one dir, main page]

WO2008009860A3 - Use of calcium channel antagonist compounds for depigmenting the skin - Google Patents

Use of calcium channel antagonist compounds for depigmenting the skin Download PDF

Info

Publication number
WO2008009860A3
WO2008009860A3 PCT/FR2007/051687 FR2007051687W WO2008009860A3 WO 2008009860 A3 WO2008009860 A3 WO 2008009860A3 FR 2007051687 W FR2007051687 W FR 2007051687W WO 2008009860 A3 WO2008009860 A3 WO 2008009860A3
Authority
WO
WIPO (PCT)
Prior art keywords
depigmenting
skin
calcium channel
channel antagonist
antagonist compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2007/051687
Other languages
French (fr)
Other versions
WO2008009860A2 (en
Inventor
Lionel Breton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0653062A external-priority patent/FR2903901B1/en
Application filed by LOreal SA filed Critical LOreal SA
Publication of WO2008009860A2 publication Critical patent/WO2008009860A2/en
Anticipated expiration legal-status Critical
Publication of WO2008009860A3 publication Critical patent/WO2008009860A3/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to the use of at least one calcium channel antagonist compound for depigmenting and/or bleaching the skin.
PCT/FR2007/051687 2006-07-21 2007-07-18 Use of calcium channel antagonist compounds for depigmenting the skin Ceased WO2008009860A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0653062A FR2903901B1 (en) 2006-07-21 2006-07-21 USE OF CALCIUM CHANNEL ANTAGONIST COMPOUNDS FOR DEPIGMENTING THE SKIN.
FR0653062 2006-07-21
US83380606P 2006-07-28 2006-07-28
US60/833,806 2006-07-28

Publications (2)

Publication Number Publication Date
WO2008009860A2 WO2008009860A2 (en) 2008-01-24
WO2008009860A3 true WO2008009860A3 (en) 2009-06-18

Family

ID=38957137

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2007/051687 Ceased WO2008009860A2 (en) 2006-07-21 2007-07-18 Use of calcium channel antagonist compounds for depigmenting the skin

Country Status (1)

Country Link
WO (1) WO2008009860A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2936149B1 (en) 2008-09-23 2013-01-04 Francois Fauran USE OF ALVERINE IN THE TREATMENT OF SKIN DISEASES
JP5377927B2 (en) * 2008-10-29 2013-12-25 株式会社ファンケル Whitening agent
AU2009331298B2 (en) * 2008-12-22 2015-04-30 Pola Chemical Industries Inc. Melanin production inhibitor
JP5781443B2 (en) * 2009-01-16 2015-09-24 ネオキュティス エスアー Calcium sequestration compositions and methods for treating skin pigmentation disorders and conditions
US8293218B2 (en) 2010-07-29 2012-10-23 Conopco, Inc. Skin care compositions comprising substituted monoamines
US8476251B2 (en) 2010-07-29 2013-07-02 Conopco, Inc. Skin care compositions comprising substituted diamines
WO2018224615A1 (en) * 2017-06-08 2018-12-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treating hyperpigmentation disorders

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1003002A6 (en) * 1989-03-21 1991-10-22 Coppe Jan Formulation to be applied for the treatment of baldness and methods makinguse thereof
EP1053745A1 (en) * 1999-05-18 2000-11-22 L'oreal Use of at least a calcium-channel-inhibitor in the treatment of wrinkles
WO2002049603A1 (en) * 2000-12-20 2002-06-27 Lg Household & Health Care Ltd. Compositions for prevention and alleviation of skin wrinkles
KR20060052748A (en) * 2006-04-21 2006-05-19 주식회사 그린원일 Cosmetic composition comprising salt of novel hydroxyaniline derivative

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1003002A6 (en) * 1989-03-21 1991-10-22 Coppe Jan Formulation to be applied for the treatment of baldness and methods makinguse thereof
EP1053745A1 (en) * 1999-05-18 2000-11-22 L'oreal Use of at least a calcium-channel-inhibitor in the treatment of wrinkles
WO2002049603A1 (en) * 2000-12-20 2002-06-27 Lg Household & Health Care Ltd. Compositions for prevention and alleviation of skin wrinkles
KR20060052748A (en) * 2006-04-21 2006-05-19 주식회사 그린원일 Cosmetic composition comprising salt of novel hydroxyaniline derivative

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JO Y K ET AL: "Whitening cosmetic composition comprising hydroxyaniline derivative salts which inhibit activity of tyrosinase and melanine formation without side-effects", WPI / THOMSON,, 1 January 1900 (1900-01-01), XP002431384 *

Also Published As

Publication number Publication date
WO2008009860A2 (en) 2008-01-24

Similar Documents

Publication Publication Date Title
GB0609497D0 (en) Structured composite compositions for treatment of subterranenan wells
WO2008011560A3 (en) Benzothiophene inhibitors of rho kinase
WO2008112199A8 (en) Method for inhibiting topoisomerase ii
IL197668A0 (en) Rna antagonist compounds for the modulation of pcsk9
IL183938A0 (en) Amino - imidazolones for the inhibition of ?? - becretase
IL184303A0 (en) Amino-pyridines as inhibitors of ??-secretase
WO2008051416A3 (en) Compounds that inhibit the activity of hsp90 for treating infections
IL195341A0 (en) Methods and materials for making simvastatin and related compounds
WO2008067219A3 (en) Quinazolinone modulators of tgr5
ZA200807862B (en) Azolopyrimidines as inhibitors of cannabinoid 1 activity
WO2007150015A3 (en) Method of treatment
WO2009009041A3 (en) Compositions and methods for modulating a kinase cascade
ZA200808750B (en) Co-granulates of bleach activator-peroxide compounds
IL213694A0 (en) Melanin production inhibitor compounds and compositions comprising the same
ZA200802848B (en) Potassium channel inhibitors
GB0912562D0 (en) LXR-antagonists for the prevention, reduction or inhibition of scarring
WO2008009860A3 (en) Use of calcium channel antagonist compounds for depigmenting the skin
GB0909297D0 (en) Composition for the treatment of skin conditions
EP2073634A4 (en) Stabilized prostaglandin e composition
WO2006128143A3 (en) Hydantoin compounds
PL1963280T3 (en) 2-phenylethylamino derivatives as calcium and/or sodium channel modulators
WO2007050348A3 (en) Potassium channel inhibitors
PL1912640T3 (en) Use of the hdac inhibitor panobinostat for the treatment of myeloma
AU2006260779A8 (en) Lavatory block composition
WO2010148177A3 (en) Compounds, compositions, methods of synthesis, and methods of treatment

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07823606

Country of ref document: EP

Kind code of ref document: A2